Replimune Group Long Term Debt Current 2011-2026 | REPL

Annual Long Term Debt Current Replimune Group

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.18 M	1.16 M	1.12 M	1.07 M	970 K	873 K	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.18 M	873 K	1.06 M

Long Term Debt Current of other stocks in the Biotechnology industry

Issuer	Long Term Debt Current	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	3.63 M	-	2.43 %	$ 254 M	Germany
Grifols, S.A. GRFS	117 M	$ 7.72	1.85 %	$ 6.83 B	Spain
Amphastar Pharmaceuticals AMPH	7.93 M	$ 19.68	0.92 %	$ 920 M	USA
Amarin Corporation plc AMRN	2.15 M	$ 14.5	0.03 %	$ 6.02 B	Irlanda
GlaxoSmithKline plc GSK	137 M	$ 52.37	1.02 %	$ 173 B	Britain
I-Mab IMAB	8.06 M	-	-	$ 866 M	China
Ascendis Pharma A/S ASND	14.2 M	$ 221.59	-0.13 %	$ 5 B	Danmark
Autolus Therapeutics plc AUTL	5.05 M	$ 1.39	1.46 %	$ 355 M	Britain
Applied Genetic Technologies Corporation AGTC	1.27 M	-	-	$ 26.5 M	USA
ARCA biopharma ABIO	213 K	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	271 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	428 K	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	1.59 M	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	3.08 M	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	48 K	-	10.36 %	$ 9.8 M	USA
Acasti Pharma ACST	75 K	-	4.01 %	$ 150 M	Canada
Heron Therapeutics HRTX	3.04 M	$ 0.81	3.74 %	$ 135 M	USA
Adverum Biotechnologies ADVM	5.67 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	104 K	-	2.71 %	$ 14 M	USA
Advaxis ADXS	166 K	-	-9.65 %	$ 45.9 M	USA
Ayala Pharmaceuticals AYLA	419 K	-	-	$ 7.46 M	Israel
Benitec Biopharma BNTC	354 K	$ 11.05	0.64 %	$ 455 M	USA
Atreca BCEL	3.54 M	-	-11.76 %	$ 5.79 M	USA
BeiGene, Ltd. BGNE	20.7 M	-	0.49 %	$ 251 B	Cayman-islands
Calithera Biosciences CALA	1.37 M	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	1.92 M	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	2.81 M	-	-	$ 3.74 B	USA
Immunovant IMVT	98 K	$ 24.1	4.85 %	$ 3.65 B	USA
Bellerophon Therapeutics BLPH	203 K	-	-74.18 %	$ 955 K	USA
Incyte Corporation INCY	5.7 M	$ 90.36	-0.47 %	$ 17.6 B	USA
InMed Pharmaceuticals INM	376 K	$ 0.74	-9.75 %	$ 1.81 M	Canada
INmune Bio INMB	119 K	$ 1.17	-0.43 %	$ 21 M	USA
Aeglea BioTherapeutics AGLE	625 K	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	3.47 M	-	-	$ 867 M	Germany
Compugen Ltd. CGEN	768 K	$ 2.13	1.91 %	$ 199 M	Israel
Arbutus Biopharma Corporation ABUS	425 K	$ 4.43	4.6 %	$ 735 M	Canada
Akouos AKUS	671 K	-	0.23 %	$ 488 M	USA